Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+2.3%
5Y CAGR+22.4%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+2.3%/yr
Quarterly compound
5Y CAGR
+22.4%/yr
Recent deceleration
Percentile
P82
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 72.73% |
| Q3 2025 | 17.98% |
| Q2 2025 | 24.25% |
| Q1 2025 | -19.31% |
| Q4 2024 | 15.76% |
| Q3 2024 | 48.02% |
| Q2 2024 | -11.06% |
| Q1 2024 | 21.51% |
| Q4 2023 | -24.42% |
| Q3 2023 | 492.47% |
| Q2 2023 | 73.82% |
| Q1 2023 | 236.88% |
| Q4 2022 | 67.89% |
| Q3 2022 | -500.80% |
| Q2 2022 | 108.44% |
| Q1 2022 | 4.10% |
| Q4 2021 | -0.70% |
| Q3 2021 | 2.45% |
| Q2 2021 | 4.15% |
| Q1 2021 | -111.36% |
| Q4 2020 | 26.47% |
| Q3 2020 | -7.10% |
| Q2 2020 | -57.64% |
| Q1 2020 | 146.25% |
| Q4 2019 | 37.15% |
| Q3 2019 | -1.11% |
| Q2 2019 | -13.30% |
| Q1 2019 | 1.99% |
| Q4 2018 | 102.10% |
| Q3 2018 | 131.31% |
| Q2 2018 | 33.32% |
| Q1 2018 | -3.03% |
| Q4 2017 | -9.52% |
| Q3 2017 | 10.09% |
| Q2 2017 | -31.11% |
| Q1 2017 | -24.25% |
| Q4 2016 | 18.64% |
| Q3 2016 | -17.87% |
| Q2 2016 | -243.54% |
| Q1 2016 | 58.47% |